vastatin〔J〕.Am J Physiol Heart Circ Physiol ,2003;285(3):H93845.
13 Girgis RE,Frost AE,Hill NS,et al.Selective endothelin a receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease〔J〕.Ann Rheum Dis,2007;66(11):146772.
14 Girgis RE,Mozammel S,Champion HC,et al.Regression of chronic hypoxic pulmonary hypertension by simvastatin〔J〕.Am J Physiol Lung Cell Mol Physiol,2007;292(5):L110510.
15 Sperling RT,Creager MA.Nitric oxide and pulmonary hypertension〔J〕. Coron Artery Dis,1999;10(5):28794.
16 Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease:an AsiaPacific perspective〔J〕.Respirology,2005;10(1):917.
17 张彦,贺蓓,赵鸣武,等.慢性阻塞性肺病患者α1抗胰蛋白酶的研究〔J〕.中华医学杂志,2005;85(18):12703.
18 Davignon J,Mabile L.Mechanisms of action of statins and their pleiotropic effects〔J〕.Ann Endocrinol (Paris),2001;62(1 Pt 2):10112.
19 Novack V,Eisinger M,Frenkel A,et al.The effects of statin therapy on inflammatory cytokines in patients with bacterial infections:a randomized doubleblind placebo controlled clinical trial〔J〕.Intensive Care Med,2009;35(7):125560.
20 Lee JS,Rosengart MR,Kondragunta V,et al.Inverse association of plasma IL13 and inflammatory chemokines with lung function impairment in stable COPD:a crosssectional cohort study〔J〕.Respir Res,2007;8(1):64.
21 Lee JH,Lee DS,Kim EK,et al.Simvastatin inhibits cigarette smokinginduced emphysema and pulmonary hypertension in rat lungs〔J〕.Am J Respir Crit Care Med,2005;172(8):98793.
仁和医学论文网专业提供代写代发医学论文服务,并提供大量论文资料,如有业务需求请咨询网站客服人员!
上一页 [1] [2] [3] [4]